vs
Clipper Realty Inc.（CLPR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Clipper Realty Inc.的1.9倍（$69.8M vs $37.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -30.4%，领先414.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -2.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 1.8%）
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CLPR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.9倍
$37.1M
营收增速更快
RIGL
高出23.8%
-2.6%
净利率更高
RIGL
高出414.4%
-30.4%
两年增速更快
RIGL
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.1M | $69.8M |
| 净利润 | $-11.3M | $268.1M |
| 毛利率 | -5.2% | 91.5% |
| 营业利润率 | 21.8% | 33.2% |
| 净利率 | -30.4% | 384.0% |
| 营收同比 | -2.6% | 21.2% |
| 净利润同比 | -938.6% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLPRRIGL
| Q4 25 | $37.1M | $69.8M | ||
| Q3 25 | $37.7M | $69.5M | ||
| Q2 25 | $39.0M | $101.7M | ||
| Q1 25 | $39.4M | $53.3M | ||
| Q4 24 | $38.0M | $57.6M | ||
| Q3 24 | $37.6M | $55.3M | ||
| Q2 24 | $37.3M | $36.8M | ||
| Q1 24 | $35.8M | $29.5M |
净利润CLPRRIGL
| Q4 25 | $-11.3M | $268.1M | ||
| Q3 25 | $-4.6M | $27.9M | ||
| Q2 25 | $-1.4M | $59.6M | ||
| Q1 25 | $-35.1M | $11.4M | ||
| Q4 24 | $-1.1M | $14.3M | ||
| Q3 24 | $-1.1M | $12.4M | ||
| Q2 24 | $-1.7M | $-1.0M | ||
| Q1 24 | $-2.7M | $-8.2M |
毛利率CLPRRIGL
| Q4 25 | -5.2% | 91.5% | ||
| Q3 25 | 23.6% | 93.2% | ||
| Q2 25 | 27.8% | 95.6% | ||
| Q1 25 | -34.5% | 91.7% | ||
| Q4 24 | 28.8% | 89.9% | ||
| Q3 24 | 28.6% | 85.5% | ||
| Q2 24 | 26.8% | 92.4% | ||
| Q1 24 | 25.4% | 93.1% |
营业利润率CLPRRIGL
| Q4 25 | 21.8% | 33.2% | ||
| Q3 25 | 23.6% | 40.9% | ||
| Q2 25 | 27.7% | 60.1% | ||
| Q1 25 | -59.9% | 23.9% | ||
| Q4 24 | 28.1% | 28.9% | ||
| Q3 24 | 28.6% | 25.4% | ||
| Q2 24 | 26.8% | 1.2% | ||
| Q1 24 | 25.4% | -23.6% |
净利率CLPRRIGL
| Q4 25 | -30.4% | 384.0% | ||
| Q3 25 | -12.2% | 40.2% | ||
| Q2 25 | -3.5% | 58.6% | ||
| Q1 25 | -89.1% | 21.5% | ||
| Q4 24 | -2.9% | 24.9% | ||
| Q3 24 | -2.9% | 22.5% | ||
| Q2 24 | -4.7% | -2.8% | ||
| Q1 24 | -7.5% | -27.9% |
每股收益（稀释后）CLPRRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-30.7M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CLPRRIGL
| Q4 25 | $30.8M | $155.0M | ||
| Q3 25 | $26.1M | $137.1M | ||
| Q2 25 | $32.0M | $108.4M | ||
| Q1 25 | $21.3M | $77.1M | ||
| Q4 24 | $19.9M | $77.3M | ||
| Q3 24 | $18.6M | $61.1M | ||
| Q2 24 | $20.3M | $49.1M | ||
| Q1 24 | $21.9M | $49.5M |
总债务CLPRRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $1.3B | $60.0M | ||
| Q4 24 | $1.3B | $60.0M | ||
| Q3 24 | $1.3B | $60.0M | ||
| Q2 24 | $1.2B | $60.0M | ||
| Q1 24 | $1.2B | $60.0M |
股东权益CLPRRIGL
| Q4 25 | $-30.7M | $391.5M | ||
| Q3 25 | $-25.0M | $117.6M | ||
| Q2 25 | $-21.9M | $81.9M | ||
| Q1 25 | $-20.1M | $18.6M | ||
| Q4 24 | $-5.4M | $3.3M | ||
| Q3 24 | $-3.6M | $-14.6M | ||
| Q2 24 | $-1.8M | $-29.9M | ||
| Q1 24 | $279.0K | $-31.7M |
总资产CLPRRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $1.2B | $206.7M | ||
| Q1 25 | $1.3B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.3B | $139.4M | ||
| Q2 24 | $1.3B | $128.4M | ||
| Q1 24 | $1.3B | $126.5M |
负债/权益比CLPRRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4396.73× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLPRRIGL
| Q4 25 | $22.6M | $22.0M | ||
| Q3 25 | $1.4M | $24.0M | ||
| Q2 25 | $8.4M | $30.5M | ||
| Q1 25 | $6.7M | $-893.0K | ||
| Q4 24 | $31.9M | $14.5M | ||
| Q3 24 | $6.3M | $21.7M | ||
| Q2 24 | $8.8M | $302.0K | ||
| Q1 24 | $6.3M | $-5.0M |
自由现金流CLPRRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.6M | — | ||
| Q4 24 | $-37.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-14.7M | — |
自由现金流率CLPRRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -11.7% | — | ||
| Q4 24 | -99.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -41.1% | — |
资本支出强度CLPRRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.6% | — | ||
| Q4 24 | 183.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 58.6% | — |
现金转化率CLPRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
RIGL
暂无分部数据
